Objective. The beneficial effect of human leukocyte antigen (HLA) matching on long-term prognosis in penetrating keratoplasty is now unequivocal but has to be weighed against the additional waiting period on an individual basis. HLAMatchmaker is a molecularly based algorithm for histocompatibility determination that can identify immunologically acceptable mis-matches and thus potentially reduce time on the wait-ing list dramatically without negatively affecting prognosis. Methods. The HLAMatchmaker algorithm (triplet-string matching) was applied on each of 545 normal-risk keratoplasties for which complete HLA type was known at split-level resolution. Two homogenous groups were defined. Group I consisted of the 147 pen
This report addresses the concept that permissible HLA mismatching, that is, mismatches that do not ...
ABSTRACT: Highly sensitized renal transplant candi-dates present a group at high risk for acute and ...
PURPOSE: A randomised trial to test the hypothesis that human leucocyte antigen (HLA) class II match...
A previous issue of the ASHI Quarterly introduced HLAMatchmaker as a matching program that considers...
textabstractAIM: To establish if coincidental HLA-A, HLA-B, and HLA-DR tissue matching is asso...
TRANSPLANT candidates are generally consideredhighly alloimmunized if their serum panel-reactive ant...
Background. In highly sensitized patients (HSP) awaiting renal transplantation, accurate delineation...
Background. HLA Matchmaker is a computer algorithm developed to evaluate donor/ receptor compatibil...
ABSTRACT: HLAMatchmaker is a computer algorithm that assesses human leukocyte antigen (HLA) compatib...
Both donor-specific anti-human leukocyte antigen (HLA) antibodies and cytotoxic T lymphocytes are im...
AbstractThis report addresses the concept that permissible HLA mismatching, that is, mismatches that...
ABSTRACT: This report describes an algorithm for identifying acceptable HLA antigens for highly allo...
Background: The matching of favorable human leukocyte antigen (HLA) combinations is rarely performed...
BACKGROUND: Graft rejection. Twenty to thirty percent of patients with corneal transplants experienc...
Background. Human leukocyte antigen (HLA) matching strategies for kidney transplantation assign equa...
This report addresses the concept that permissible HLA mismatching, that is, mismatches that do not ...
ABSTRACT: Highly sensitized renal transplant candi-dates present a group at high risk for acute and ...
PURPOSE: A randomised trial to test the hypothesis that human leucocyte antigen (HLA) class II match...
A previous issue of the ASHI Quarterly introduced HLAMatchmaker as a matching program that considers...
textabstractAIM: To establish if coincidental HLA-A, HLA-B, and HLA-DR tissue matching is asso...
TRANSPLANT candidates are generally consideredhighly alloimmunized if their serum panel-reactive ant...
Background. In highly sensitized patients (HSP) awaiting renal transplantation, accurate delineation...
Background. HLA Matchmaker is a computer algorithm developed to evaluate donor/ receptor compatibil...
ABSTRACT: HLAMatchmaker is a computer algorithm that assesses human leukocyte antigen (HLA) compatib...
Both donor-specific anti-human leukocyte antigen (HLA) antibodies and cytotoxic T lymphocytes are im...
AbstractThis report addresses the concept that permissible HLA mismatching, that is, mismatches that...
ABSTRACT: This report describes an algorithm for identifying acceptable HLA antigens for highly allo...
Background: The matching of favorable human leukocyte antigen (HLA) combinations is rarely performed...
BACKGROUND: Graft rejection. Twenty to thirty percent of patients with corneal transplants experienc...
Background. Human leukocyte antigen (HLA) matching strategies for kidney transplantation assign equa...
This report addresses the concept that permissible HLA mismatching, that is, mismatches that do not ...
ABSTRACT: Highly sensitized renal transplant candi-dates present a group at high risk for acute and ...
PURPOSE: A randomised trial to test the hypothesis that human leucocyte antigen (HLA) class II match...